• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于依托芬那酯的化学性质,一种来自N-芳基邻氨基苯甲酸衍生物系列的新型抗炎剂(作者译)]

[On the chemistry of etofenamate, a novel anti-inflammatory agent from the series of N-arylanthranilic acid derivatives (author's transl)].

作者信息

Boltze K H, Kreisfeld H

出版信息

Arzneimittelforschung. 1977;27(6B):1300-12.

PMID:579118
Abstract

Etofenamate is 2-(2-hydroxyethoxy)ethyl-N-(a,a,a,-trifluorom-tolyl)anthranilate and has been selected as an antiphlogistic agent for percutaneous therapy. Its characteristic alcohol-ether-ester structure brings about an increase in lipophilia and in its ability to penetrate through the intact skin. Furthermore, its oily consistency renders it ideal for pharmaceutical formulation in gels. The physico-chemical material constants, partition coefficients (RM values) as a measure for lipophilia, spectra and molecular models of etofenamate are described. Various methods of synthesis of etofenamate and of its intermediates are described. Structural identification is made of by-products simultaneously obtained in the reaction. Pure etofenamate is obtained through repeated molecular distillation. The synthesis is carried out uniformly with protected reaction components and, after splitting off the protective groups, extremely pure etofenamate is obtained.

摘要

依托芬那酯是2-(2-羟基乙氧基)乙基-N-(α,α,α-三氟间甲苯基)邻氨基苯甲酸酯,已被选作经皮治疗的抗炎剂。其独特的醇-醚-酯结构使其亲脂性增加,穿透完整皮肤的能力增强。此外,其油性稠度使其成为凝胶剂药物制剂的理想选择。描述了依托芬那酯的物理化学物质常数、作为亲脂性度量的分配系数(RM值)、光谱和分子模型。描述了依托芬那酯及其中间体的各种合成方法。对反应中同时得到的副产物进行了结构鉴定。通过反复分子蒸馏获得纯依托芬那酯。合成过程中使用受保护的反应组分统一进行,脱除保护基团后得到极纯的依托芬那酯。

相似文献

1
[On the chemistry of etofenamate, a novel anti-inflammatory agent from the series of N-arylanthranilic acid derivatives (author's transl)].[关于依托芬那酯的化学性质,一种来自N-芳基邻氨基苯甲酸衍生物系列的新型抗炎剂(作者译)]
Arzneimittelforschung. 1977;27(6B):1300-12.
2
[Synthesis and properties of nuclear hydroxylated derivatives of flufenamic acid and etofenamate (author's transl)].氟芬那酸和依托芬那酯的核羟基化衍生物的合成与性质(作者译)
Arzneimittelforschung. 1982;32(3):183-6.
3
[Pharmacology and toxicology of etofenamate. 1st Communication (author's transl)].依托芬那酯的药理学与毒理学。首次通讯(作者译)
Arzneimittelforschung. 1977;27(6B):1326-33.
4
[Analysis of etofenamate. Particular determination in biological material (author's transl)].[依托芬那酯分析。生物材料中的特殊测定(作者译)]
Arzneimittelforschung. 1977;27(6B):1312-6.
5
[Pharmacology and toxicology of etofenamate. 2].[依托芬那酯的药理学与毒理学。2]
Arzneimittelforschung. 1977;27(6B):1333-40.
6
Etofenamate fatty acid asters. An example of a new route of drug metabolism.依托芬那酯脂肪酸星状物。药物代谢新途径的一个实例。
Drug Metab Dispos. 1982 Jan-Feb;10(1):55-60.
7
[Studies on metabolism and elimination of etofenamate by dogs (author's transl)].犬对依托芬那酯的代谢与排泄研究(作者译)
Arzneimittelforschung. 1981;31(1):21-6.
8
[Metabolism of etofenamate / Identification and analytic of metabolites, their pharmacological properties and species dependence of metabolism (author's transl)].[依托芬那酯的代谢/代谢产物的鉴定与分析、其药理学特性及代谢的物种依赖性(作者译)]
Arzneimittelforschung. 1981;31(1):9-16.
9
[Anti-edema activity of a trans-cutaneous non-steroidal anti-inflammatory agent, etofenamate gel, in rats].[经皮非甾体抗炎药依托芬那酯凝胶对大鼠的抗水肿活性]
Nihon Yakurigaku Zasshi. 1982 Aug;80(2):169-82.
10
[Experience with etofenamate in sport injuries (author's transl)].依托芬那酯治疗运动损伤的经验(作者译)
Arzneimittelforschung. 1977;27(6B):1355-7.

引用本文的文献

1
Clinical Efficacy and Safety Profile of Topical Etofenamate in the Treatment of Patients with Musculoskeletal Disorders: A Systematic Review.外用依托芬那酯治疗肌肉骨骼疾病患者的临床疗效和安全性概况:一项系统评价
Pain Ther. 2020 Dec;9(2):393-410. doi: 10.1007/s40122-020-00177-1. Epub 2020 Jun 19.